Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson's Disease

Background. Parkinson's disease (PD) progressively affects dopaminergic neurotransmission and may affect retinal dopaminergic functions and structures. Objective. This 2-year randomized, open-label, parallel-group, flexible-dose study, NCT00144300, evaluated ophthalmologic safety profiles of im...

Descripción completa

Detalles Bibliográficos
Autores principales: Seiple, William, Jennings, Danna, Rosen, Richard B., Borchert, Leona, Canale, Lee, Fagan, Nora, Gordon, Mark Forrest
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203898/
https://www.ncbi.nlm.nih.gov/pubmed/28078162
http://dx.doi.org/10.1155/2016/8298503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203898/
https://www.ncbi.nlm.nih.gov/pubmed/28078162
http://dx.doi.org/10.1155/2016/8298503

Ejemplares similares